Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Identification of a Cell Line That Expresses a Cell Surface and a Soluble Form of the gp330/Receptor-Associated Protein (RAP) Heymann Nephritis Antigenic Complex

Robert A. Orlando and Marilyn Gist Farquhar
Proceedings of the National Academy of Sciences of the United States of America
Vol. 90, No. 9 (May 1, 1993), pp. 4082-4086
Stable URL: http://www.jstor.org/stable/2361896
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Identification of a Cell Line That Expresses a Cell Surface and a Soluble Form of the gp330/Receptor-Associated Protein (RAP) Heymann Nephritis Antigenic Complex
Preview not available

Abstract

gp330 is a large glycoprotein located in clathrin-coated pits at the surface of the glomerular and proximal tubule epithelia in the rat kidney. It was originally identified as the target of autoimmune antibodies in Heymann nephritis (HN) and has since been shown to be a member of the low density lipoprotein receptor gene family and to form a stable association with receptor-associated protein (RAP), which together constitute the HN antigen complex (HNAC). Progress in defining the normal functions of gp330 as well as the molecular mechanisms of HN has been hampered by the lack of an available kidney cell line that expresses this protein. We here report the identification of a rat yolk sac carcinoma cell line (L2) that synthesizes HNAC and expresses it in coated pits at the cell surface. gp330 and RAP from L2 cells are immunologically identical to their kidney counterparts, and peptide maps of gp330 yielded identical peptide fragments. Characterization of the cell line revealed that there are 3.3 x 104 gp330 molecules per L2 cell and that the cells produce a soluble form of gp330 that is released into the medium. Heparin ligand blot analysis demonstrated that RAP but not gp330 binds heparin. By heparin affinity chromatography, gp330 and RAP copurify, indicating that the glycosaminoglycan binding site within RAP is accessible when the subunit is complexed with gp330. These results indicate that the L2 cell line provides a valid and useful model for studies on the function of HNAC and the pathogenesis of HN.

Page Thumbnails

  • Thumbnail: Page 
4082
    4082
  • Thumbnail: Page 
4083
    4083
  • Thumbnail: Page 
4084
    4084
  • Thumbnail: Page 
4085
    4085
  • Thumbnail: Page 
4086
    4086